Adapting Enhanced Recovery Programs for Low Health Literacy Patients
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Apr 4, 2024
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the care of patients with low health literacy who are undergoing surgery. Low health literacy means that some patients may have difficulty understanding medical information, which can lead to longer hospital stays and more complications after surgery. The study will test a program called VISACT, which uses visual aids, helps doctors communicate better, and trains healthcare organizations to support patients with low health literacy. By making these improvements, the researchers hope to enhance recovery programs and ultimately improve patient outcomes.
To participate in this study, individuals must be at least 18 years old and undergoing surgery as part of an enhanced recovery program. Caregivers and healthcare providers involved in the program are also eligible. Participants need to be able to understand and consent to the study, and they must speak English. The trial is not yet recruiting participants, but those who join can expect to be part of a pilot program that aims to create better support systems for patients with low health literacy, helping to reduce disparities in surgical care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients \>= 18 years of age undergoing surgery under an enhanced recovery program (ERPs)
- • Adult caregivers/providers, organizational leaders, \>= 18 years of age with direct or indirect involvement with ERP implementation
- • All genders
- • All race/ethnicities
- • Able to consent
- • English-speaking
- Exclusion Criteria:
- • Child (\<18 years of age)
- • Patients undergoing operations not included under ERPs
- • Participants unable to consent for the study
- • Participants whose mental state excludes them from being able to understand contents of the informed consent form and/or patients whose family members or patient representative do not wish for them to participate in the study
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Daniel I Chu, MD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported